Congress Program
08:00-09:00
Registration
09:00-09:05
Congress Opening & Welcome
Prof. Jacob Schachter, Sheba Medical Center, Israel | Prof. Dr. Dirk Schadendorf, University Hospital Essen, Germany
09:05-10:30
Session 1
Chair: Prof. Jacob Schachter, Israel
09:05-09:30
Immunotherapy of cancer; how far have we come?
09:30-09:55
Predicting response to immunotherapy
Pier Francesco Ferrucci
European Institute of Oncology (IEO), Italy
09:55-10:20
Immunotherapy management in special patient population
Mario Mandalà
Papa Giovanni XXIII Hospital in Bergamo, Italy
10:20-10:30
Discussion / Q&A
10:30-11:00
Coffee Break, Poster Viewing and Visit the Exhibition
11:00-12:30
Session 2
11:00-11:25
The future role of immunotherapy as a basic platform for the treatment of cancer
Dirk Jäger
National Center for Tumor Diseases (NCT) Heidelberg, Germany
11:25-11:50
Transforming "COLD" to "HOT" Tumors
Guy Ben-Betzalel
Sheba Medical Center, Israel
11:50-12:15
Can Radiotherapy help cancer immunotherapy?
12:15-12:30
Discussion / Q&A
12:30-13:30
Lunch Break, Poster Viewing and Visit the Exhibition
13:30-15:00
Session 3
Chair: Prof. Dr. Dirk Jäger, Germany
13:30-13:55
Peptid-based and T-cell Therapy of cancer
Jens Bauer
University of Tübingen, Germany
13:55-14:20
Targeted Cell-based Therapy in Cancer Treatment
14:20-14:45
The concept of immunotherapy combinations
Jacob Schachter
Sheba Medical Center, Israel
14:45-15:00
Discussion / Q&A
15:00-15:30
Coffee Break, Poster Viewing and Visit the Exhibition
15:30-16:30
Session 4
Chair: Prof. Dr. Dirk Schadendorf, Germany
15:30-15:55
Concept and first results of neoadjuvant immunotherapy in solid tumors
Dirk Schadendorf
University Hospital Essen, Germany
15:55-16:30
Case Studies
Shirly Grynberg
Sheba Medical Center, Israel
16:30
End of Day One
08:30-09:00
Registration
09:00-09:05
Congress Welcome - Day 2
Prof. Jacob Schachter, Sheba Medical Center, Israel | Prof. Dr. Dirk Schadendorf, University Hospital Essen, Germany
09:05-10:30
Session 5
Chair: Prof. Dr. Dirk Schadendorf, Germany
09:05-09:30
Immunotherapy in urogenital malignancies
Viktor Grünwald
University Hospital Essen, Germany
09:30-09:55
The Algorithm of the Treatment of Advanced Melanoma and Non-Melanoma Skin Cancer
Philippe Saiag
University of Versailles-SQY & University Paris-Saclay, France
09:55-10:20
Personalized Treatment of Immunotherapy Toxicity
10:20-10:30
Discussion / Q&A
10:30-11:00
Coffee Break, Poster Viewing and Visit the Exhibition
11:00-12:30
Session 6
Chair: Prof. Dr. Viktor Grünwald, Germany
11:00-11:25
Updates on Immunotherapy of G.I Malignancies
11:25-11:50
Updates on immunotherapy of gynecological cancer
Ronnie Shapira-Frommer
Sheba Medical Center, Israel
11:50-12:15
Updates on the treatment of NSCLC & SCLC
Wilfried Eberhardt
University Hospital Essen, Germany
12:15-12:30
Discussion / Q&A
12:30-13:30
Lunch Break, Poster Viewing and Visit the Exhibition
13:30-14:00
Special Lecture
13:30-14:00
Oncology Care in 2030
Jacob Schachter
Sheba Medical Center, Israel
14:00-15:00
Oral Abstract Presentations
15:00-15:30
Coffee Break, Poster Viewing and Visit the Exhibition
15:30-16:30
Session 7
Chair: Prof. Jacob Schachter, Israel
15:30-16:30
Case Studies
Shirly Grynberg
Sheba Medical Center, Israel
16:30
End of Congress
